Hospital Geral de Fortaleza

Fortaleza, Ceará 60175-295

0 studies enrolling now · 3 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Delayed Graft Function, High-risk Transient Ischemic Attack, LGI1 Autoimmune Encephalitis, NMDAR Autoimmune Encephalitis, Prevention of Ischemic Stroke

Studies at this site

• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis — Running, not enrolling
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant — Completed